Address correspondence to Dr Terry D. Fife, Barrow Neurological Institute, 240 W Thomas Rd, Ste 301, Phoenix, AZ 85013, [email protected].
RELATIONSHIP DISCLOSURE: Drs Fife and Tourkevich report no disclosures.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Drs Fife and Tourkevich discuss the unlabeled/investigational use of carbamazepine, gabapentin, oxcarbazepine, or pregabalin for the treatment of certain types of pulsatile pulse-asynchronous tinnitus; baclofen, carbamazepine, clonazepam, onabotulinumtoxinA, or oxcarbazepine for the treatment of palatal or middle ear myoclonus; and betahistine for the treatment of Ménière disease.